Search

Your search keyword '"Asamura, H."' showing total 733 results
Start Over Author "Asamura, H."
733 results on '"Asamura, H."'

1. P2.25-03 Functional Independence of Older Adults after Lung Cancer Surgery: Final Analysis of a Prospective Observational Study

Author

Mizutani, T., primary, Takei, H., additional, Kunitoh, H., additional, Wakabayashi, M., additional, Sekino, Y., additional, Tsuboi, M., additional, Ikeda, N., additional, Asamura, H., additional, Okada, M., additional, Takahama, M., additional, Ohde, Y., additional, Okami, J., additional, Shiono, S., additional, Aokage, K., additional, and Watanabe, S., additional

Published
2023
Full Text
View/download PDF

2. EP08.02-10 Clinicopathological Analyses for Predicting Survival After Salvage Surgery for Initially Unresectable Lung Cancer

Author

Oka, N., primary, Hishida, T., additional, Kaseda, K., additional, Oshiro, Y., additional, Sakurada, A., additional, Sugino, K., additional, Aoki, H., additional, Ishiguro, Y., additional, Imoto, T., additional, Okubo, Y., additional, Masai, K., additional, Asakura, K., additional, Emoto, K., additional, and Asamura, H., additional

Published
2023
Full Text
View/download PDF

7. 944P Hazard function analysis of recurrence in patients with curatively resected lung cancer: Results from the Japanese Lung Cancer Registry in 2010

Author

Yamauchi, Y., primary, Kawamura, M., additional, Okami, J., additional, Shintani, Y., additional, Ito, H., additional, Ohtsuka, T., additional, Toyooka, S., additional, Mori, T., additional, Watanabe, S-I., additional, Asamura, H., additional, Chida, M., additional, Endo, S., additional, Kadokura, M., additional, Nakanishi, R., additional, Miyaoka, E., additional, Yoshino, I., additional, and Date, H., additional

Published
2022
Full Text
View/download PDF

9. 1788P Final overall survival analysis of JCOG1205/1206: Phase III study of irinotecan/cisplatin (IP) versus etoposide/cisplatin (EP) for completely resected high-grade neuroendocrine carcinoma (HGNEC) of the lung

Author

Niho, S., Kenmotsu, H., Tsuboi, M., Wakabayashi, M., Ishii, G., Asahina, H., Watanabe, K., Kiyoshima, M., Iwata, T., Nakamura, Y., Naoki, K., Yoshikawa, T., Nishino, K., Nishio, W., Yokoyama, T., Mitome, N., Asamura, H., Ohe, Y., and Watanabe, S-I.

Published
2024
Full Text
View/download PDF

11. Lung Carcinoma

Author

Asamura, H., Naruke, T., Hermanek, P., editor, Gospodarowicz, Mary K., editor, Henson, D. E., editor, Hutter, R. V. P., editor, and Sobin, L. H., editor

Published
1995
Full Text
View/download PDF

12. OA06.04 Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset

Author

Osarogiagbon, R., primary, Nishimura, K., additional, Porta, R. Rami, additional, Montuenga, L., additional, Giroux, D., additional, Suda, K., additional, Araujo, L., additional, Detterbeck, F., additional, Gautschi, O., additional, Kerr, K., additional, Kneuertz, P., additional, Mack, P., additional, Matilla, J., additional, Nicholson, A., additional, Pass, H., additional, Presley, C., additional, Terra, R., additional, Wistuba, I., additional, Yang, D., additional, Yatabe, Y., additional, Travis, W., additional, Tsao, M., additional, Asamura, H., additional, Rusch, V., additional, Hirsch, F., additional, and Carbone, D., additional

Published
2021
Full Text
View/download PDF

13. FP01.04 Prospective Observational Study of Activities of Daily Livings in Elderly Patients After Lung Cancer Surgery (JCOG1710A)

Author

Takei, H., primary, Kunitoh, H., additional, Wakabayashi, M., additional, Kataoka, T., additional, Mizutani, T., additional, Tsuboi, M., additional, Ikeda, N., additional, Asamura, H., additional, Okada, M., additional, Takahama, M., additional, Ohde, Y., additional, Okami, J., additional, Shiono, S., additional, Aokage, K., additional, and Watanabe, S., additional

Published
2021
Full Text
View/download PDF

14. Tumours of the lung : introduction

Author

Tsao, M.S., Asamura, H., Borczuk, A.C., Dacic, S., Devesa, S.S., Kerr, K.M., MacMahon, H., Rusch, V.W., Samet, J.M., Scagliotti, G.V, Travis, W.D, van Schil, Paul, Yatabe, Y., and Znaor, A.

Subjects
Human medicine
Published
2021

20. MiniSTR multiplex systems based on non-CODIS loci for analysis of degraded DNA samples

Author

Asamura, H., Fujimori, S., Ota, M., and Fukushima, H.

Subjects
Chromosome abnormalities -- Research, Japanese -- Genetic aspects, Law
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.forsciint.2007.01.015 Byline: H. Asamura, S. Fujimori, M. Ota, H. Fukushima Keywords: Autosomal miniSTR; Quadruplex; Non-CODIS loci; Japanese population; Degraded DNA Abstract: We describe two short amplicon autosomal short tandem repeat (miniSTR) quadruplex systems for eight loci D1S1171, D2S1242, D3S1545, D4S2366, D12S391, D16S3253, D20S161, and D21S1437, unlinked from the combined DNA index system (non-CODIS) loci, using newly designed primer sets. The results of an assay of 411 Japanese individuals showed that polymerase chain reaction (PCR) products within the eight loci were less than 150bp in size, without the seven additional bases for adenylation. The frequency distributions in the loci showed no deviations from Hardy-Weinberg equilibrium expectations. The accumulated power of discrimination and power of exclusion for the eight loci were 0.9999999991 and 0.998, respectively. For assay of highly degraded DNA, including artificially degraded samples and the degraded forensic casework samples assessed with the present miniSTR quadruplex systems, the systems proved quite effective in analyzing degraded DNA. Author Affiliation: Department of Legal Medicine, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto, Nagano 390-8621, Japan Article History: Received 7 December 2006; Revised 18 January 2007; Accepted 19 January 2007

Published
2007

28. Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids

Author

Filosso, P. L., Guerrera, F., Falco, N. R., Thomas, P., Garcia Yuste, M., Rocco, G., Welter, S., Moreno Casado, P., Rendina, E. A., Venuta, F., Ampollini, L., Nosotti, M., Raveglia, F., Rena, O., Stella, F., Larocca, V., Ardissone, F., Brunelli, A., Margaritora, S., Travis, W. D., Sagan, D., Sarkaria, I., Evangelista, A., Yuste, M. G., Lim, E., Papagiannopoulos, K., Asamura, H., Filosso, Pier Luigi, Guerrera, Francesco, Falco, Nicola Rosario, Thomas, Pascal, Garcia Yuste, Mariano, Rocco, Gaetano, Welter, Stefan, Moreno Casado, Paula, Rendina, Erino Angelo, Venuta, Federico, Ampollini, Luca, Nosotti, Mario, Raveglia, Federico, Rena, Ottavio, Stella, Franco, Larocca, Valentina, Ardissone, Francesco, Brunelli, Alessandro, Margaritora, Stefano, Travis, William D, Sagan, Dariusz, Sarkaria, Inderpal, Evangelista, Andrea, Yuste, Mariano Garcia, Lim, Eric, Papagiannopoulos, Konstantino, and Asamura, Hisao

Subjects
Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Thoracic, overall survival, Medizin, Carcinoid Tumor, 030204 cardiovascular system & hematology, lung neoplasms, surgery, 03 medical and health sciences, 0302 clinical medicine, male, Interquartile range, Settore MED/21 - CHIRURGIA TORACICA, middle aged, Medicine, Humans, Cumulative incidence, carcinoid tumor, Stage (cooking), Pneumonectomy, humans, Lung, pneumonectomy, Aged, Retrospective Studies, business.industry, Proportional hazards model, Hazard ratio, Retrospective cohort study, General Medicine, Middle Aged, Surgery, aged, retrospective studies, typical carcinoid, female, 030228 respiratory system, Propensity score matching, Female, business, Cardiology and Cardiovascular Medicine, neoplasm, Wedge resection (lung)
Abstract

OBJECTIVES Typical carcinoids (TCs) are rare, slow-growing neoplasms, usually characterized by satisfactory surgical outcomes. Due to the rarity of TCs, international guidelines for the management of particular clinical presentations currently do not exist. In particular, non-anatomical resections (wedges) are sometimes advocated for Stage 1 TCs because of their indolent behaviour. The aim of this paper was to evaluate the most effective type of surgery for Stage 1 TCs, using the European Society of Thoracic Surgeons retrospective database of the Neuroendocrine Tumors of the Lung Working Group. METHODS We analysed the effect of surgical procedure on the survival of patients with Stage 1 TCs. Overall survival (OS) was calculated from the date of intervention. The cumulative incidence of cause-specific death (tumour- and non-tumour-related) was also estimated. The impact of the surgical procedure (i.e. lobectomy vs segmentectomy vs wedge resection) on survival was investigated using the Cox model with shared frailty (for OS, accounting for the within-centre correlation) and the Fine and Gray model (for cause-specific mortality) using the approach based on the multinomial propensity score. Effects were estimated including in the model the logit-transformed propensity scores of segmentectomy and wedge resection as covariates. RESULTS A total of 876 patients with Stage 1 TCs (569 women, 65%) were included in this study. The median age was 60 years (interquartile range 47–69). At the last follow-up, 66 patients had died: The 5-year OS rate was 94.3% [95% confidence interval (CI) 92.2–95.9]. The 5-year cumulative incidences of tumour- and non-tumour-related deaths were 2.4% (95% CI 1.4–3.9) and 3.9% (95% CI 2.5–5.6%), respectively. The analysis performed using the multinomial propensity score approach confirmed the significantly worse survival of patients treated with a wedge resection compared to those treated with a lobectomy (hazard ratio 2.01, 95% CI 1.09–3.69; P = 0.024). Similar effects of wedge resection are detectable for cause-specific deaths: tumour-related (hazard ratio 2.28, 95% CI 0.86–6.02; P = 0.096) and non-tumour-related (hazard ratio 1.74, 95% CI 0.89–3.40; P = 0.105). CONCLUSIONS In a large cohort of patients, we were able to demonstrate the superiority of anatomical surgical resection in Stage 1 TCs in terms of OS. This result should therefore be considered for future clinical guidelines for the management of TCs.

Published
2019

33. MA06.06 A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer

Author

Kunitoh, H., primary, Sakurai, H., additional, Tsuboi, M., additional, Wakabayashi, M., additional, Okada, M., additional, Suzuki, K., additional, Ikeda, N., additional, Takahama, M., additional, Takenoyama, M., additional, Ohde, Y., additional, Yoshiya, K., additional, Matsumoto, I., additional, Yamashita, M., additional, Marutsuka, T., additional, Date, H., additional, Hasumi, T., additional, Yamashita, Y., additional, Okumura, N., additional, Watanabe, S., additional, and Asamura, H., additional

Published
2019
Full Text
View/download PDF

38. Direct Reprogramming of Mouse Fibroblasts into Pulmonary Epithelial-Like Cells

Author

Kusumoto, T., primary, Ishii, M., additional, Yotsukura, M., additional, Hegab, A.E., additional, Saito, F., additional, Hamamoto, J., additional, Asakura, T., additional, Kamata, H., additional, Namkoong, H., additional, Suzuki, S., additional, Okamori, S., additional, Ogawa, T., additional, So, M., additional, Asamura, H., additional, Ieda, M., additional, and Betsuyaku, T., additional

Published
2019
Full Text
View/download PDF

43. P3.16-05 A Nanotechnology-Enabled Strategy for Image-Guided Transbronchial and Transpleural Photothermal Therapy of Peripheral Lung Cancer

Author

Kinoshita, T., primary, Ujiie, H., additional, Chen, J., additional, Ding, L., additional, Chan, H., additional, Gregor, A., additional, Bernards, N., additional, Mcveigh, P., additional, Fujino, K., additional, Lee, C., additional, Motooka, Y., additional, Inage, T., additional, Valic, M., additional, Weersink, R., additional, Wilson, B., additional, Zheng, G., additional, Asamura, H., additional, and Yasufuku, K., additional

Published
2018
Full Text
View/download PDF

47. Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group

Author

Rice, D., Rusch, V., Pass, H, Asamura, H, Nakano, T., Edwards, J., Giroux, D.J., Hasegawa, S., Kernstine, K.H., Waller, D., Rami-Porta, R., Postmus, P.E., Eberhardt, Wilfried (Beitragende*r), University of Zurich, Pulmonary medicine, and CCA - Innovative therapy

Subjects
Extrapleural Pneumonectomy, Mesothelioma, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Consensus, Lung Neoplasms, Thoracic Surgical Procedure, 10255 Clinic for Thoracic Surgery, Pleural Neoplasms, medicine.medical_treatment, Medizin, 610 Medicine & health, Pleural neoplasm, medicine, Humans, Pleural Neoplasm, Lung cancer, Neoplasm Staging, business.industry, International Agencies, Thoracic Surgical Procedures, Decortication, medicine.disease, Surgery, Pneumothorax, Oncology, 2740 Pulmonary and Respiratory Medicine, Public Opinion, Practice Guidelines as Topic, 2730 Oncology, nomenclature, business, Pleurectomy
Abstract

Introduction Extrapleural pneumonectomy has been well defined; however, surgeons vary regarding the surgical extent and goals of "pleurectomy/decortication" (P/D). We explored mesothelioma surgeons' concepts of P/D with the aim of unifying surgical nomenclature. Methods A web-based survey was administered to surgeons who operated on malignant pleural mesothelioma (MPM) for diagnosis, staging, palliation, or cytoreduction. One hundred thirty surgeons from 59 medical centers were included. Surgeons who did not perform surgery for MPM within the last year were excluded. Results There were 62 (48%) respondents from 39 medical centers in 14 countries. The mean number of patients with MPM seen annually at each medical center was 46, and the mean annual number of cytoreductive procedures performed per surgeon was 8. Most (88%) agreed that the goal of cytoreductive surgery should be macroscopic complete resection of tumor. P/D was defined as resection of parietal and visceral pleura with the aim of achieving macroscopic complete resection by 72% of respondents. If the diaphragm or pericardium required resection, 64% preferred the term "radical P/D," whereas "P/D" (40%) or "total pleurectomy" (39%) was preferred if these structures were not removed. Most surgeons believed that extrapleural pneumonectomy (90%) or "radical P/D" (68%) could provide adequate cytoreduction, whereas only 23% thought that P/D could. Conclusions There was significant variation regarding surgical nomenclature for procedures for MPM. The International Staging Committee of the International Association for the Study of Lung Cancer and the International Mesothelioma Interest Group recommend that P/D should aim to remove all macroscopic tumor involving the parietal and visceral pleura and should be termed "extended" P/D when the diaphragm or pericardium is resected.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results